Case Reports

Radioiodine Therapy for Hyperthyroidism in a Patient with End-Stage Renal Disease on Hemodialysis: Case Report

10.5350/BTDMJB201410207

  • Müge Tamam
  • Mehmet Mülazımoğlu
  • Nurcan Edis
  • Ercan Uyanık
  • Tevfik Özpaçacı

Received Date: 01.09.2011 Accepted Date: 07.04.2013 Med J Bakirkoy 2014;10(2):75-77

Toxic nodular goiter is a rare entity in end-stage renal disaese (ESRD) patients. In ESRD patients, hypothyroidism is generally seen, whereas hyperthyroidism is rare. Treatment with radioactive iodine (RAI) may be necessary for hyperthyroidism in patients with end-stage renal disease who require haemodialysis. Because RAI is cleared mainly by the kidneys in patients with normal renal function, many problems may (issues) arise in patients who are on hemodialysis but require RAI treatment. We present an ESRD patient with hyperthyroidism who is receiving hemodialysis treated with radioiodine therapy.

Keywords: Hyperthyroidism, hemodialysis, radioiodine theraphy